Abstract

Cardiovascular disorders are among the foremost causes of death worldwide, especially hypertension, a silent killer syndrome that requires multiple drug therapy for proper management. This work presents novel and green spectrophotometric methods for the concurrent analysis of Amlodipine (AML), Telmisartan (TEL), Hydrochlorothiazide (HCTZ), and Chlorthalidone (CLO) in their pharmaceutical dosage form. The suggested methods were Fourier-self deconvolution, amplitude factor, and first derivative methods developed and validated for the simultaneous determination of a tertiary mixture of AML, TEL, and HCTZ in TELVAS 3D 80 mg tablet and a binary mixture of TEL and CLO in TELMIKIND-CT 40 tablets. The investigated methods revealed limits of detection 0.7283 µg/ml for AML and ranging from 0.0121 to 0.0433, 0.1547 to 0.1767 µg/ml and 0.0578 to 0.1262 µg/ml for TEL, HCTZ, and CLO, respectively.The greenness of the suggested techniques was examined by an eco-scale scoring method called the penalty points, which revealed that the methods were excellent green regarding several parameters as reagents, instrument, and waste safety. The introduced methods’ validity was investigated by resolving prepared laboratory mixtures containing different AML, TEL, HCTZ, or TEL and CLO ratios. Furthermore, the introduced methods were ensured by the standard addition technique. Finally, the obtained results were statistically compared by the reported spectrophotometric methods, showing no significant difference concerning precision and accuracy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call